Deep Genomics
ON - TorontoBiotechnology
Focus: Deep Genomics is an AI-driven biotechnology company specializing in oligonucleotide therapy discovery, leveraging machine learning to identify novel genetic targets. The company operates at mid-scale (51-200 employees) and is publicly listed, positioning itself at the intersection of genomics and artificial intelligence.
Profile data last refreshed 19m ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
2-2 this month
Stable — net -2 jobs in 30d
1 added, 3 removed. Backfill posture.
Should You Work at Deep Genomics?
AI assessmentBest fit for AI/ML and computational biology specialists seeking early-stage discovery impact with public-company stability; less suitable for those prioritizing clinical-stage visibility or traditional pharma structure.
Why Work Here
- Join a cutting-edge AI-discovery platform where machine learning directly drives therapeutic development rather than supporting functions.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Deep Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.